News Articles


Biomarker for prognosis in endometrial carcinoma

TMA enometrical cancer.jpg

Loss of ASRGL1 expression is an independent biomarker for disease-specific survival in endometrioid endometrial carcinoma

The ASRGL1 protein is a novel, powerful, and independent biomarker for prognosis in endometrial carcinoma.

In a recent study by scientists from the Human Protein Atlas project and collaborators at the University of Bergen and University of Turku, the l-asparaginase (ASRGL1) protein was identified as an endometrial carcinoma biomarker candidate by searches in the HPA-database.

ASRGL1 expression was immunohistochemically evaluated on two large independent endometrial carcinoma cohorts using an extensively validated antibody...Read more


Upcoming Events


Precision Health: Molecular Basis, Technology and Digital Health

November 13, 2019 - November 16, 2019

Emma Lundberg will give a talk on "Spatial proteomics and cell biology" at the EMBO Workshop, Precision Health: Molecular Basis, Technology and Digital Health, held at EMBL Heidelberg, Germany.